Assyro AI

Orange Book product · Generic (ANDA)

LITHIUM CITRATE

LITHIUM CITRATE

Generic (ANDA)ANDA 070755TE AARX PAI HOLDINGS PHARM

At a glance

May 21, 1986

Approved

Generic (ANDA)

Application

AA

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    May 21, 1986

    40 yr 8 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

LITHIUM CITRATE

Strength

EQ 300MG CARBONATE/5ML

Dosage form

SYRUP

Route

ORAL

TE code

AA

Application

ANDA 070755

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of LITHIUM CITRATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.